BioLamina
Stockholm-based BioTech scale-up specialising in matrix biology and cell culture,
BioLamina has raised €20M across 1 funding round from 1 investor, most recently a round in Apr 2026. Based in Stockholm, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Stockholm, Swedenbiolamina.com ↗
Total raised
€20M
€20,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-04
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDBioLamina — funding by year — interactive chart.
Data table
| BioLamina — funding by year | |
|---|---|
| 2026 | €20M |
Signals
High confidenceRaise-next likelihood26
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-17 | Other | €20M | European Investment Bank (EIB) | View deal → |